A Randomized Crossover Clinical Trial to Evaluate the Efficacy of Oral Transmucosal Fentanyl Citrate in the Treatment of Dyspnea on Exertion in Patients With Advanced Cancer

American Journal of Hospice and Palliative Medicine

Volumn 32, Issue 3, 2015, Pages 298-304

  Pinna, Miguel Ángel Cuervo ^a   Bruera, Eduardo ^b   Moralo, María José Redondo ^a   Correas, Miguel Ángel Sánchez ^a   Vargas, Rafael Mota ^a  

^a Regional Palliative Care Program of Extremadura   (Spain)

^b Department of Palliative Care Rehabilitation Medicine FT McGraw Chair in the Treatment of Cancer Houston   (United States)

Author keywords

advanced cancer; dyspnea; exertion; oral transmucosal fentanyl citrate

Indexed keywords

FENTANYL; NARCOTIC ANALGESIC AGENT;

AGED; CANCER STAGING; COMPLICATION; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFECTS; DYSPNEA; EXERCISE; FEMALE; GASTROINTESTINAL ABSORPTION; HUMAN; MALE; MIDDLE AGED; NEOPLASM; PAIN; RANDOMIZED CONTROLLED TRIAL;

AGED; ANALGESICS, OPIOID; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DYSPNEA; FEMALE; FENTANYL; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS; ORAL MUCOSAL ABSORPTION; PAIN; PHYSICAL EXERTION;

EID: 84927510117     PISSN: 10499091     EISSN: 19382715     Source Type: Journal    
DOI: 10.1177/1049909113513063     Document Type: Article

References (21)

1. Mechanisms, assessment, and management: a consensus statement. American thoracic society.Am J Respir Crit Care Med. 1999;159 (1): 321-340
2. Bruera E,Schmitz B,Pither J,Neumann CM,Hanson J.The frequency and correlates of dyspnea in patients with advanced cancer.J Pain Symptom Manage. 2000;19 (5): 357-362
3. Simon ST,Bausewein C,Schildmann E, et al.Episodic breathlessness in patients with advanced disease: a systematic review.J Pain Symptom Manage. 2013;45 (3): 561-578
4. Cuervo Pinna MA,Mota Vargas R,Redondo Moralo MJ,Sánchez Correas MA,Pera Blanco G.Dyspnea—a bad prognosis symptom at the end of life.Am J Hosp Palliat Care. 2009;26 (2): 89-97
5. Jennings AL,Davies AN,Higgins JP,Gibbs JS,Broadley KE.A systematic review of the use of opioids in the management of dyspnoea.Thorax. 2002;57 (11): 939-944
6. Ben-Aharon I,Gafter-Gvili A,Paul M,Leibovici L,Semmer SM.Interventions for alleviating cancer-related dyspnea: a systematic review.J Clin Oncol. 2008;26 (14): 2396-2404
7. Viola R,Kiteley C,Lloyd NS,Mackay JA,Wilson J,Wong RK.The management of dyspnea in cancer patients: a systematic review.Support Care Cancer. 2008;16 (4): 329-337
8. Smith TJ,Coyne P,French W,Ramakrishnan V,Corrigan P.Failure to accrue to a study of nebulized fentanyl for dyspnea: lessons learned.J Palliat Med. 2009;12 (9): 771-772
9. Benitez-Rosario MA,Martin AS,Feria M.Oral transmucosal fentanyl citrate in the management of dyspnea crises in cancer patients.J Pain Symptom Manage. 2005;30 (5): 395-397
10. Gauna AA,Kang SK,Triano ML,Swatko ER,Vanston VJ.Oral transmucosal fentanyl citrate for dyspnea in terminally ill patients: an observational case series.J Palliat Med. 2008;11 (4): 643-648
11. Senn SCross-Over Trials in Clinical Research. 2nd ed. Chichester: Wiley; 2002.Chichester: Wiley; 2002:
12. Koch GG.The use of non-parametric methods in the statistical analysis of the two-period change-over design.Biometrics. 1972;28 (2): 577-584
13. Johnson MJ,Bland JM,Oxberry SG,Abernethy AP,Currow DC.Clinically important differences in the intensity of chronic refractory breathlessness [published online April 19, 2013].J Pain Symptom Manage. 2013;:
14. Bruera E,Sala R,Spruyt O,Palmer JL,Zhang T,Willey J.Nebulized versus subcutaneous morphine for patients with cancer dyspnea: a preliminary study.J Pain Symptom Manage. 2005;29 (6): 613-618
15. Jensen D,Alsuhail A,Viola R,Dudgeon DJ,Webb KA,O'Donnell DE.Inhaled fentanyl citrate improves exercise endurance during high-intensity constant work rate cycle exercise in chronic obstructive pulmonary disease.J Pain Symptom Manage. 2012;43 (4): 706-719
16. Coyne PJ,Viswanathan R,Smith TJ.Nebulized fentanyl citrate improves patients’ perception of breathing, respiratory rate, and oxygen saturation in dyspnea.J Pain Symptom Manage. 2002;23 (2): 157-160
17. Sitte T,Bausewein C.Intranasal fentanyl for episodic breathlessness.J Pain Symptom Manage. 2008;36 (6): e3-e5
18. Clemens KE,Klaschik E.Effect of hydromorphone on ventilation in palliative care patients with dyspnea.Support Care Cancer. 2008;16 (1): 93-99
19. Charles MA,Reymond L,Israel F.Relief of incident dyspnea in palliative cancer patients: a pilot, randomized, controlled trial comparing nebulized hydromorphone, systemic hydromorphone, and nebulized saline.J Pain Symptom Manage. 2008;36 (1): 29-38
20. ATS statement: guidelines for the six-minute walk test.Am J Respir Crit Care. 2002;166 (1): 111-117
21. Coyne PJ,Viswanathan R,Smith TJ.Nebulized fentanyl citrate improves patients’ perception of breathing, respiratory rate, and oxygen saturation in dyspnea.J Pain Symptom Manage. 2002;23 (2): 157-160